ArnaudBastienMD

PubMed

• 638 citations
  Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin:a randomised, double-blind, placebo-controlled trial
  Clifford J. Bailey, Jorge Luiz Gross, Anne Pieters, Arnaud Bastien, James F. List
  Lancet. 2010-06-26
• 30 citations
  Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
  Connie Kingry, Arnaud Bastien, Gillian L. Booth, Therese S. Geraci, Brenda Kirpach
  The American Journal of Cardiology. 2007-06-18
• 287 citations
  A Study of Dapagliflozin in Patients With Type 2 Diabetes Receiving High Doses of Insulin Plus Insulin Sensitizers Applicability of a novel insulin-independent treatment
  John P.H. Wilding, Paul Norwood, Caroline T'joen, Arnaud Bastien, James F. List
  Diabetes Care. 2009-09-01

Journal Articles

• Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus  
  Gerich John E; Bastien Arnaud, Expert Review of Clinical Pharmacology, 1/1/2011
• A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers  
  John P.H. Wilding, MD; Paul Norwood, MD; Caroline T’Joen, MSC; Arnaud Bastien, MD; James F List, MD PHD; Fred T. Fiedorek, MD, Diabetes Care, 1/1/2009
• Management of High Blood Pressure in Clinical Practice: Perceptible Qualitative Differences in Approaches Utilized by Clinicians  
  Nwachuku, Bastien, Cutler, Grob, Margolis, Rocella, Pressel, Davis, Caso, Sheps, and Weber J, Clinical Hypertension, 1/1/2008
• Blood Pressure Control by Drug Group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)  
  William C. Cushman, MD ; Charles E. Ford, PhD; Paula T. Einhorn, MD, MS ; Jackson T. Wright Jr, MD, PhD; Richard A. Preston, MD; Barry R. Davis, MD, PhD; Jan N. Basi..., Clinical Hypertension, 1/1/2008
• Health-Related Quality of Life and Cost-Effectiveness Components of the Action to control Cardiovascular Risk in Diabetes (ACCORD) Trial: Rationale and Design  
  Mark D. Sullivan MD, PhD, Roger T Anderson PHD, David Aron MD MS, Hal Atkinson MD, Arnaud Bastien MD, John Chen MD PhD et al, J.AmJCard, 1/18/2007
• Recruitment Strategies in the Action to control Cardiovascular Risk in Diabetes (ACCORD) Trial  
  Connie Kingry, RN, BSN, Arnaud Bastien, MD , Gillian Booth, MD, MSC , Therese S. Geraci, MSN, Brenda Kirpach, CCRA, Laura C Lovato, MS, Karen Margolis, MD, MPH, Yves ..., J.AmJCard, 1/18/2007
• Mitigating Cardiovascular Risks in Diabetes  
  Arnaud Bastien, MD, Practical Diabetology, 1/14/2007
• "Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic" The Antihypertensive a...  
  Arnaud Bastien MD, JAMA, 1/1/2002
• "Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care" The Antihypertensive and Lipid-Lowering Treatment to...  
  Arnaud Bastien MD, JAMA, 1/1/2002
• HIV in the Inner Cities: Epidemiologic Trends and their Influence on Policy Making Decisions  
  Arnaud Bastien, MD, Journal of Community Health, 1/1/1995
• The ACCORD Trial: A Multidisciplinary Approach to Control Cardiovascular Risk in Type 2 Diabetes Mellitus  
  The ACCORD Study Group, Practical Diabetology
• Join now to see all

Abstracts/Posters

• Management of High Blood Pressure in Clinical Practice: Perceptible Qualitative Differences in Approaches Utilized by Clinicians
  Arnaud Bastien MD, Michael Caso, Jeffrey A. Cutler MD, Barry R Davis MD PhD, Glenda Grob, Karen Margolis MD, Chuke Nwachuku MA MPH DrPH; Edward Rocella PhD; Sheldon Sh..., J. Clinical Hypertension, 1/1/2007
• Validity and Predictors of Adherence to Metformin In a Multiracial Clinical Trial
  Margolis, KL.; Hildebrant; Sereika, SM.; Bastien, A.; Lovato, JF.; Nwachuku, C, 2nd Scientific Conference on Compliance in Healthcare and Research; Circulation, Washington, DC, 1/17/2004
• Human Papilloma virus (HPV) Is More Common Among Younger Women with Cervical Ectopy or Coital Bleeding: A Report from the Heterosexual HIV Transmission Study
  Kelly, P; Vermund, SH; Bromberg, J; DeHovitz, JA; Bastien, A; Handte, J; Landesman ,SH; Burk, RD, VIII International Conference on AIDS, Amsterdam, Holland, 1/1/1992
• Retention in a Women's HIV Transmission Cohort: Combining Clinical Care with Health Education as a Strategy for Retention
  American Public Health Association Annual Meetings, Washington, DC, 1/1/1992
• Bastien, A.; DeHovitz, JA; Covino, JM; Smith B.; Landesman, SH; Stevens, R.; McCormack, W., VI International Conference on AIDS, San Francisco, CA, 1/1/1990
• A Model for cooperation Between an University Medical Center (UMC) and Community Based Operations (CBO's) Responding to HIV Disease
  Bastien, A; Freedman, P; Conde, A; Sinclair, L; DeHovitz, JA, VI International Conference on AIDS, San Francisco, CA, 1/1/1990
• Are Women at Risk More Likely to Seek Voluntary Testing Than Men?
  Bastien, A.; DeHovitz,lA; Smith,B;Covino,1M; Landesman,SH; Stevens, R.; McCormack, W., American Public Health Association Annual Meeting, New York, NY, 1/1/1990
• Implementing a culturally sensitive AIDS Prevention Program for Haitian Immigrants in New York
  Bastien, A.; Freedman, P.; Norat, Y.; DeHovitz, JA., AIDS: the Scientific and Social Challenge; V International Conference on AIDS, Montreal, Canada, 1/1/1989
• HIV Infection in Patients Attending a Hospital Based Sexually Transmitted Diseases Clinic
  DeHovitz, JA.; Freedman, P.; Bastien, A.; Norat, Y., AIDS: the Scientific and Social Challenge; V International Conference on AIDS, 1/1/1989
• Differences between Symptomatic HIV (+) Female and Male Patients
  Kelly, P.; Graham, V.; DeHovitz, JA.; Hall, L.; Kitchens, A.; Bastien, A., AIDS: the Scientific and Social Challenge; V International Conference on AIDS, 1/1/1989
• P. Kelly, S.H. Vermund; J. DeHovitz; J.; Bromberg; A. Bastien; J. Handle; S. Landesman; and R.D. Burk, Multiple presentations
• Join now to see all